In our previous investigations, we could demonstrate that extract preparations of Hypericum perforatum (St. John's wort, SJW) inhibit the uptake of several neurotransmitters (serotonin, norepinephrine, dopamine, GABA, L-glutamate) in synaptosomal preparations of rodent brain. Hyperforin, the lipophilic constituent, was identified as the main component responsible for these effects. The properties seen for hyperforin in these and other pharmacological models present a plausible and logical explanation for the well documented antidepressive effects of SJW extract preparations in clinical studies. However, evidence for other active principles in SJW extract have been reported [2]
[3] (See also communications by Misane & Ögren and Philippu in this issue). Accordingly, we tested various SJW extract preparations and all relevant constituents as possible inhibitors of synaptosomal uptake of neurotransmitters. Two further components were found to be active in those models. Adhyperforin, like hyperforin, showed a strong inhibiting profile in all uptake systems investigated. Moreover, we could observe a weak to moderate inhibiting profile for the oligomeric procyanidins fraction (OPC). Further investigations would have to clarify any possible contribution of these two constituents to the antidepressive effects of SJW extract seen in animal experiments and clinical trials.
References
-
1
Bhattacharya S K, Chakrabarti A, Chatterjee S S.
Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.
Pharmacopsychiatry.
1998;
31
(Suppl. 1)
22-29
-
2
Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstedt A.
Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.
Pharmacopsychiatry.
1997;
30
(Suppl. 2)
117-124
-
3
Butterweck V, Petereit F, Winterhoff H, Nahrstedt A.
Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.
Planta Med.
1998;
64
291-294
-
4
Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H.
Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test.
Planta Med.
2000;
66
3-6
-
5
Chatterjee S S, Bhattacharya S K, Wonnemann K, Singer A, Müller W E.
Hyperforin as a possible antidepressant component of hypericum extracts.
Life Sci.
1998;
63
499-510
-
6
De Vry J, Maurel S, Schreiber R, de Beun R, Jentzsch K R.
Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism.
Eur Neuropsychopharmacol.
1999;
9
461-468
-
7
Dimpfel W, Schober F, Mannel M.
Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Pharmacopsychiatry.
1998;
31
(Suppl. 1)
30-35
-
8
Kaehler S T, Sinner C, Chatterjee S S, Philippu A.
Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus.
Neurosci Lett.
1999;
262
199-202
-
9
Melzer R, Fricke U, Holzl J.
Vasoactive properties of procyanidins from Hypericum perforatum L. in isolated porcine coronary arteries.
Arzneimittelforschung.
1991;
41
481-483
-
10
Müller W E, Rolli M, Schafer C, Hafner U.
Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.
Pharmacopsychiatry.
1997;
30
(Suppl. 2)
102-107
-
11
Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C.
Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.
Pharmacopsychiatry.
1998;
31
(Suppl. 1)
16-21
-
12
Nahrstedt A, Butterweck V.
Biologically Active and Other Chemical Constituents of the Herb of Hypericum perforatum L.
Pharmacopsychiatry.
1997;
30
(Suppl. 2)
129-134
-
13
Schellenberg R, Sauer S, Dimpfel W.
Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
Pharmacopsychiatry.
1998;
31
(Suppl. 1)
44-53
-
14
Singer A, Wonnemann M, Müller W E.
Hyperforin, a major antidepressant constituent of St. John's wort, inhibits serotonin uptake by elevating free intracellular Na1+ ions.
J Pharmacol Exp Ther.
1999;
290
1363-1368
-
15
Wonnemann M, Singer A, Müller W E.
Inhibition of Synaptosomal Uptake of 3H-L-glutamate and 3H-GABA by Hyperforin, a Major Constituent of St. John's Wort. The Role of Amiloride Sensitive Sodium Conductive Pathways.
Neuropsychopharmacology.
2000;
23
188 -197
Prof. Dr. Walter E. Müller
Dept. Pharmacol.
Univ. Frankfurt
Biocenter N260
Marie-Curie-Straße 9
60439 Frankfurt
Germany
